Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

If the treatment is approved for everyone eligible, the State’s drugs budget could more than double, a doctors’ conference heard ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

Popular weight-loss and type 2 diabetes drugs such as ... But the introduction of new oral drugs raises a lot of new questions as well, Cavender says. Do different pills require different dosing ...